Witness the unveiling of the next 15 prescription drugs eligible for price negotiations with Medicare by the Biden administration. This marks a significant step towards making expensive medications more accessible to seniors.
Among these drugs are Novo Nordisk’s popular diabetes treatment Ozempic, weight loss solution Wegovy, and diabetes medication Rybelsus. These products all contain semaglutide as their active ingredient, revolutionizing the obesity drug market but posing challenges for patients due to cost and availability.
The agreed-upon prices for these medications will take effect in 2027, providing relief to many individuals struggling with affordability issues. Stay tuned for updates on this groundbreaking initiative!
2025-01-17 18:36:07
Link from www.cnbc.com